Capital Access Advisory Program — Building Companies

📋 Eligible Entities - Private companies operating in the healthcare and life sciences sectors - Early-stage to growth-stage companies with viable technology or innovations - Canadian-based businesses (incorporated or operating in Canada) - Companies demonstrating commercialization potential in healthcare technology - Entities NOT eligible: Non-profits, sole proprietors (typically), government agencies, or companies without healthcare/life sciences focus ### 💰 Funding Details - Grant Type: Non-repayable advisory/mentorship program (no direct capital injection) - Funding Structure: In-kind contribution of expert guidance and strategic advisory services - No matching requirement: Program covers cost of Steering Committee access - No loan component: This is advisory support, not debt financing - Indirect value: Access to investor networks and commercialization expertise valued at significant professional consulting rates - No cash disbursement: Benefits delivered through expert time and strategic counsel ### 🛠️ Approved Expenses This program does not fund direct business expenses. Instead, it provides guidance on: - Fundraising strategy development and investor pitch refinement - Technology commercialization planning and go-to-market strategy - Business model optimization for healthcare market entry - Investor relations coaching from experienced healthcare executives - Strategic positioning for capital raises (Series A/B/C, venture debt, etc.) - Healthcare sector expertise and regulatory pathway navigation - Network access to investors and industry decision-makers ### ⚠️ Conditions & Milestones - Commitment required: Companies must actively engage with Steering Committee recommendations - Meeting cadence: Participation in regular advisory sessions (frequency determined by program) - Reporting obligations: Progress updates on commercialization milestones and fundraising activities - Focus alignment: Strategy must target healthcare technology commercialization or fundraising readiness - Confidentiality: Proprietary information shared with Committee under NDA protections - Time-bound engagement: Program typically structured for 12-24 month advisory relationship - Milestone tracking: Company must demonstrate progress toward identified commercialization or fundraising goals - **Post-program